Royce & Associates’s Psychemedics Corporation PMD Stock Holding History

Royce & Associates’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-37,500	Closed	-$191K	–	1073
2020 Q4	$191K	Hold	37,500	–	–	﹤0.01%	964
2020 Q3	$165K	Hold	37,500	–	–	﹤0.01%	945
2020 Q2	$206K	Hold	37,500	–	–	﹤0.01%	932
2020 Q1	$227K	Hold	37,500	–	–	﹤0.01%	912
2019 Q4	$343K	Hold	37,500	–	–	﹤0.01%	928
2019 Q3	$342K	Hold	37,500	–	–	﹤0.01%	938
2019 Q2	$378K	Hold	37,500	–	–	﹤0.01%	939
2019 Q1	$526K	Hold	37,500	–	–	﹤0.01%	920
2018 Q4	$595K	Hold	37,500	–	–	0.01%	916
2018 Q3	$705K	Hold	37,500	–	–	﹤0.01%	957
2018 Q2	$721K	Hold	37,500	–	–	0.01%	987
2018 Q1	$776K	Sell	37,500 -284	-0.8%	-$5.9K	0.01%	1007
2017 Q4	$777K	Buy	37,784 +13	+0%	+$241	0.01%	1010
2017 Q3	$696K	Buy	37,771 +271	+0.7%	+$5.97K	﹤0.01%	1005
2017 Q2	$936K	Hold	37,500	–	–	0.01%	984
2017 Q1	$752K	Hold	37,500	–	–	﹤0.01%	1012
2016 Q4	$926K	Hold	37,500	–	–	0.01%	954
2016 Q3	$744K	Hold	37,500	–	–	﹤0.01%	957
2016 Q2	$515K	Hold	37,500	–	–	﹤0.01%	985
2016 Q1	$516K	Hold	37,500	–	–	﹤0.01%	981
2015 Q4	$380K	Hold	37,500	–	–	﹤0.01%	1043
2015 Q3	$378K	Sell	37,500 -85,300	-69%	-$994K	﹤0.01%	1069
2015 Q2	$1.82M	Hold	122,800	–	–	0.01%	948
2015 Q1	$2.04M	Sell	122,800 -14,700	-11%	-$229K	0.01%	941
2014 Q4	$2.07M	Hold	137,500	–	–	0.01%	961
2014 Q3	$1.96M	Hold	137,500	–	–	0.01%	1011
2014 Q2	$1.95M	Hold	137,500	–	–	0.01%	1044
2014 Q1	$2.35M	Hold	137,500	–	–	0.01%	1024
2013 Q4	$2.02M	Hold	137,500	–	–	0.01%	1064
2013 Q3	$1.82M	Hold	137,500	–	–	0.01%	1088
2013 Q2	$1.48M	Buy	+137,500	New	+$1.55M	﹤0.01%	1096

Other funds holding PMD

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $6B AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Royce & Associates's PMD Position: Q1 2021 in Review

Royce & Associates sold out of Psychemedics Corporation (PMD) in Q1 2021, closing a stake of 37,500 shares — an estimated $191K sold.

Royce & Associates first reported a position in PMD in Q2 2013 and held it in 31 quarters. The position peaked at $2.35M in Q1 2014. 31 funds tracked by Wall St. Rank hold PMD as of Q1 2021.

Royce & Associates reported no remaining Psychemedics Corporation position as of Q1 2021 after selling out during the quarter.
Royce & Associates sold 37,500 Psychemedics Corporation shares in Q1 2021, an estimated $191K.
Royce & Associates first reported a position in Psychemedics Corporation in Q2 2013 and held it in 31 quarters.
Royce & Associates's Psychemedics Corporation position peaked at $2.35M in Q1 2014.
31 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2021.

Based on Royce & Associates's 13F filing for Q1 2021, filed 10 May 2021.